Account
Havas Media wins Amplifon’s integrated media mandate
MUMBAI: Havas Media Group India has won the integrated media mandate of hearing care service provider Amplifon India.
The madate comes post a keenly fought multi-agency pitch. For Havas Media, this win comes on the back of a stellar business performance in 2015 where it won more than Rs 300 crore of new business.
The account will be handled from the agency’s Gurgaon office.
Amplifon India CEO Samit Verma said, “We were impressed with Havas Media’s strategic thinking and passion. With their keen interest in our business and senior management involvement, the course has been set for a long term relationship.”
Amplifon India managing director Shveta Paul added, “We were looking for a partner who could give us strategic directions and international learnings. Havas gave us both. Besides that, we found their Meaningful Connections Planning process very relevant for our brand. We are happy to be partnering with them.”
Havas Media Group, India and South Asia CEO Anita Nayyar said, “We are privileged to win the prestigious Amplifon business. Our Meaningful Brands philosophy resonates with a brand like theirs – which has already touched many lives. We look forward to a meaningful association with them.”
Havas Media Group India MD Mohit Joshi commented, “This is a great business win. With each passing day, our confidence on our Digital At the Core approach keeps getting stronger. Today, Havas is seen as a SMART agency in the matket. We look forward to being Amplifon’s partners in their growth journey.”
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”






